Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
Journal Article (Journal Article)
The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for men choosing to participate in an early detection program for prostate cancer. These NCCN Guidelines Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. The panel stratified the age ranges at which initiating testing for prostate cancer should be considered. Indications for biopsy include both a cutpoint and the use of multiple risk variables in combination. In addition to other biomarkers of specificity, the Prostate Health Index has been included to aid biopsy decisions in certain men, given recent FDA approvals.
Full Text
Duke Authors
Cited Authors
- Carroll, PR; Parsons, JK; Andriole, G; Bahnson, RR; Barocas, DA; Catalona, WJ; Dahl, DM; Davis, JW; Epstein, JI; Etzioni, RB; Giri, VN; Hemstreet, GP; Kawachi, MH; Lange, PH; Loughlin, KR; Lowrance, W; Maroni, P; Mohler, J; Morgan, TM; Nadler, RB; Poch, M; Scales, C; Shanefelt, TM; Vickers, AJ; Wake, R; Shead, DA; Ho, M; National comprehensive cancer network,
Published Date
- September 2014
Published In
Volume / Issue
- 12 / 9
Start / End Page
- 1211 - 1219
PubMed ID
- 25190691
Electronic International Standard Serial Number (EISSN)
- 1540-1413
Digital Object Identifier (DOI)
- 10.6004/jnccn.2014.0120
Language
- eng
Conference Location
- United States